Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Facial Onset Motor and Sensory Neuronopathy Syndrome With a Novel TARDBP Mutation

Zhang, Qin, MD; Cao, Bei, MM; Chen, Yongping, MD; Liang, Yan, MM; Wei, Qianqian, MD; Zhou, Dong, MD; Shang, Huifang, MD

doi: 10.1097/NRL.0000000000000201
Case Report/Case Series
Buy
SDC

Introduction: Facial onset sensory and motor neuronopathy (FOSMN) syndrome was a rare and slowly progressive neurodegenerative disorder, which heralded by sensory symptoms within the face, and followed by evolution of sensory and motor deficits in the face and limbs. The underlying pathogenesis of FOSMN remains to be fully elucidated.

Case Report: A 40-year-old man was admitted to our hospital with facial sensory deficits spreading in a rostral-caudal manner. He then developed diffuse fasciculation, bulbar signs, atrophy and weakness of facial, neck, and limb muscles progressively, a process resembling amyotrophic lateral sclerosis. Neurophysiological studies demonstrated abnormal blink reflexes and some denervation-reinnervation changes in electromyogram. He was diagnosed with FOSMN syndrome clinically. A novel heterozygous Gly386Glu mutation in the transactive response DNA-binding protein (TARDBP) gene was found. The patient had no response to immunologic treatment and finally died of respiratory failure.

Conclusions: This is the first time that a novel mutation in TARDBP gene was identified in a patient with FOSMN syndrome, which further suggested a link between FOSMN and amyotrophic lateral sclerosis. Our findings widen the spectrum of TARDBP-related motor neuron diseases.

Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, P.R. China

Q.Z. and B.C. contributed equally.

Q.Z., B.C., and Y.C.: conceived the study and participated in drafting the manuscript, designing of the study, and performed the statistical analysis. B.C. and Y.L.: carried out the neurophysiological examination and data acquisition. Y.C. and Q.W.: carried out the molecular genetic studies. D.Z. and H.S.: participated to design the study, and helped to draft the manuscript, revise it for important intellectual content.

The authors declare no conflict of interest.

Correspondence to: Huifang Shang, MD, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China. E-mail: hfshang2002@126.com.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.